Aduro Biotech Inc.

(ADRO) Trade

By |

Profile

Aduro Biotech Inc is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies that transform the treatment of different diseases.

Contact Information

Website: www.aduro.com
Email: investors@aduro.com
Main Phone: +1 510 848-4400
Address: 740 Heinz Avenue
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710

Issuer Information

Exchange: NGS
CEO: Stephen T. Isaacs
Employees: 155
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.70 $ -0.5 (-8.06%)
Last Price 5.70 Change $ -0.5 Change % -8.06 Tick N/A
Bid 5.70 Bid Size 700.00 Ask 5.75 Ask Size 900.00
Open 6.15 High 6.35 Low 5.55 Prev Close 6.20
Last Trade Volume 214,541 52 Wk Hi 11.55 52 Wk Low 5.10
Market Cap 450.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 79,059,764.00 EPS (TTM) -1.26 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 142
Number of Buys 4 79
Number of Sells 4 63
Net Activity -2000 415748
Last 10 Buys Shares
Stephanie Monaghan O¿Brien 1,000
Stephanie Monaghan O¿Brien 1,000
Jennifer Lew 1,000
William M. Greenman 1,000
Last 10 Sell Shares
Stephen T. Isaacs 1,000
Blaine Templeman 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Elsas Andrea Van 1,000
Stephen T. Isaacs 1,000
Gregory W. Schafer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 11.38 11.38 11.38 11.38
Standard Deviation 3.2 3.2 3.2 3.2
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.43